Latin America Pharmaceuticals & Healthcare Products (16)
-
Argentina Pharmaceuticals & Healthcare Report
Pub date: 18 Aug 2011 Latin America / Argentina Pharmaceuticals & Healthcare Industry Report
BMI View: Argentina's pharmaceutical market, driven by an ageing population and resurgent economic growth, has proven a lucrative stepping stone for pharmaceutical companies looking to penetrate Lati... Read MoreWeb Price: $995 -
Brazil Pharmaceuticals & Healthcare Report
Pub date: 10 Jan 2012 Latin America / Brazil Pharmaceuticals & Healthcare Industry Report
BMI View: Brazil’s large population, combined with strong private consumption, bodes well for foreign drugmakers looking to capitalise on the growth trajectory of Latin America’s largest healthcare m... Read MoreWeb Price: $995 -
Central America Pharmaceuticals & Healthcare Report
Pub date: 25 Nov 2011 Latin America / El Salvador Pharmaceuticals & Healthcare Industry Report
BMI View: As countries are expected to invest heavily in healthcare provision over the medium term, we forecast the pharmaceutical markets of the seven states that comprise Central America to represe... Read MoreWeb Price: $995 -
Chile Pharmaceuticals & Healthcare Report
Pub date: 10 Jan 2012 Latin America / Chile Pharmaceuticals & Healthcare Industry Report
BMI View: At a value of CLP1,381bn (US$2.71bn), drug expenditure in Chile represented 1.32% of GDP in 2010, while per capita spending reached an estimated US$158. Chile’s economic development is for... Read MoreWeb Price: $995 -
Colombia Pharmaceuticals & Healthcare Report
Pub date: 30 Nov 2011 Latin America / Colombia Pharmaceuticals & Healthcare Industry Report
BMI View: On balance, the passage of the country’s free trade agreement (FTA) with the US is likely to have a positive impact for Colombia. While we anticipate the measures will usher in a series of ... Read MoreWeb Price: $995 -
Mexico Pharmaceuticals & Healthcare Report
Pub date: 18 Nov 2011 Latin America / Mexico Pharmaceuticals & Healthcare Industry Report
BMI View: Despite our generally positive outlook for much of Latin America in 2012, we maintain the view that mounting fiscal pressures and a faltering business environment will damage Mexico’s attr... Read MoreWeb Price: $995 -
Peru Pharmaceuticals & Healthcare Report
Pub date: 15 Dec 2011 Latin America / Peru Pharmaceuticals & Healthcare Industry Report
BMI View: Despite its steady growth over the past decade, Peru remains a relatively small pharmaceutical market – valued at no more than US$1.1bn in 2010 – despite the population size nudging 30mn. ... Read MoreWeb Price: $995 -
Venezuela Pharmaceuticals & Healthcare Report
Pub date: 18 Jan 2012 Latin America / Venezuela Pharmaceuticals & Healthcare Industry Report
BMI View: While Venezuela's increasingly harsh pricing regime looks unlikely to address persistent medicine shortages, President Hugo Chavez's renewed attempts to regulate the country's pharmaceutica... Read MoreWeb Price: $995 -
Burden Of Disease Database
Pub date: 29 Sep 2008 Global / Middle East Pharmaceuticals & Healthcare Special Report
Key insights from BMI’s Burden of Disease Database, an online tool that forecasts the burden of 123 diseases in 192 countries through to 2030.... Read MoreWeb Price: $490 -
Eurozone Debt Crisis: Effects on PIIGS Pharmaceuticals Market
Pub date: 24 May 2010 Global / Middle East Pharmaceuticals & Healthcare Special Report
In this report, BMI provides an analysis of the implications of the Eurozone sovereign debt crisis on the PIIGS pharmaceutical industries, with a particular focus on the impact of the austerity measur... Read MoreWeb Price: $490 -
Global Economic Downturn: Implications For The Pharmaceutical Industry
Pub date: 16 Sep 2009 Global / North America Pharmaceuticals & Healthcare Special Report
In this special report, BMI assess the impact of the economic downturn on drug expenditure levels in markets across the globe.... Read MoreWeb Price: $490 -
Pharmaceutical Pricing: Dynamics In A Global Market
Pub date: 19 Apr 2010 Global Pharmaceuticals & Healthcare Special Report
BMI analyses pharmaceutical consumer price indices across 40 countries, identifying historic and likely future trends in pricing policies and dynamics.... Read MoreWeb Price: $490 -
US Regulatory Trends During 2010: A Rapidly Changing Environment
Pub date: 25 Jan 2011 Global / North America Pharmaceuticals & Healthcare Special Report
BMI’s analysis of regulatory approvals in 2010 says much about which drugmakers will outperform rivals throughout 2011, with biological blockbuster drugs leading the way.... Read MoreWeb Price: $490 -
Brazil Pharmaceuticals Competitive Intelligence Report
Pub date: 01 Nov 2010 Latin America / Brazil Pharmaceuticals & Healthcare Competitive Intelligence Report
Brazil boasts some 550 pharmaceutical companies, which are largely generics-based. BMI estimates that the indigenous industry accounts for around 70% of the generics market segment, as measured in vo... Read MoreWeb Price: $975 -
Mexico Pharmaceuticals Competitive Intelligence Report
Pub date: 01 Nov 2010 Latin America / Mexico Pharmaceuticals & Healthcare Competitive Intelligence Report
There are around 200 registered pharmaceutical companies operating in Mexico, employing around 40,000 people. However, large-scale production is limited to approximately 40 facilities, which account ... Read MoreWeb Price: $975 -
Multinational Pharmaceuticals Companies in Latin America CD-ROM
Pub date: 01 Jan 2012 Global / Latin America Pharmaceuticals & Healthcare Multinational Companies Industry Directory
Multinational Pharmaceuticals Companies in Latin America CD-ROM... Read MoreWeb Price: $995